Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Altimmune stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALT.
You can purchase shares of Altimmune (NASDAQ:ALT) through any online brokerage.
Other companies in Altimmune’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Celcuity (NASDAQ:CELC), Sionna Therapeutics (NASDAQ:SION), Olema Pharmaceuticals (NASDAQ:OLMA) and ORIC Pharmaceuticals (NASDAQ:ORIC).
Altimmune has a consensus price target of $22.30.
The stock price for Altimmune (NASDAQ: ALT) is $4.5 last updated April 15, 2025 at 3:55 PM EDT.
There are no upcoming dividends for Altimmune.
Altimmune’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Altimmune.
Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.